Exploring a Novel Approach Using a Glyco-Immune Therapy Targeting Both Complement and Macrophages
Time: 12:00 pm
day: Day Two
Details:
- A discussion of how macrophages/microglia are involved in the pathobiology of AMD
- What are Siglecs and self-associated molecular patterns and how do they modulate immune responses?
- A novel glyco-engineered nanoparticle that inhibits over-activation of complement and macrophages
